|
ATP2A2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.80989999999781E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.367700E-04 |
| Normal-vs-Stage2 |
4.697400E-03 |
| Normal-vs-Stage3 |
1.08569999990316E-07 |
| Normal-vs-Stage4 |
7.97270000019168E-07 |
| Stage1-vs-Stage2 |
8.795400E-01 |
| Stage1-vs-Stage3 |
6.939700E-03 |
| Stage1-vs-Stage4 |
8.195400E-03 |
| Stage2-vs-Stage3 |
7.091900E-02 |
| Stage2-vs-Stage4 |
4.939700E-02 |
| Stage3-vs-Stage4 |
6.236000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.80810999999004E-05 |
| Normal-vs-AfricanAmerican |
3.218100E-03 |
| Normal-vs-Asian |
1.395530E-02 |
| Caucasian-vs-AfricanAmerican |
9.632800E-01 |
| Caucasian-vs-Asian |
1.605040E-01 |
| AfricanAmerican-vs-Asian |
3.076000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.47470000000116E-05 |
| Normal-vs-Female |
1.575370E-04 |
| Male-vs-Female |
7.607000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.680800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.8012299999981E-05 |
| Normal-vs-Age(61-80Yrs) |
1.47760000002162E-06 |
| Normal-vs-Age(81-100Yrs) |
1.601550E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.333700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.771700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.731800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.653200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.815800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.928400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.699800E-03 |
| Classical-VS-Follicular |
3.813800E-02 |
| Classical-VS-Other |
2.417600E-01 |
| Classical-VS-Normal |
1.2268000000315E-06 |
| Tall-VS-Follicular |
1.027270E-04 |
| Tall-VS-Other |
8.449800E-01 |
| Tall-VS-Normal |
5.54279999676055E-08 |
| Follicular-VS-Other |
1.962350E-01 |
| Follicular-VS-Normal |
1.822820E-01 |
| Other-VS-Normal |
7.040200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.579500E-04 |
| Normal-vs-N1 |
1.66349999997095E-06 |
| N0-vs-N1 |
6.858400E-02 |
|
|
